Lumicain (Aluminium Chloride Hexahydrate) Solution [Medical Products Laboratories, Inc.] -

LUMICAIN (ALUMINIUM CHLORIDE HEXAHYDRATE) SOLUTION [MEDICAL PRODUCTS LABORATORIES, INC.]
PDF | XML

NDC	10733-412-60
Set ID	9fdcce3e-e4d4-41ae-8609-37987c12414e
Category	HUMAN PRESCRIPTION DRUG LABEL
Packager	Medical Products Laboratories, Inc.
Generic Name
Product Class
Product Number
Application Number

View All Sections

DOSAGE & ADMINISTRATION

FOR TOPICAL APPLICATION ONLY

For Granulation Tissue Growth: Allow packing saturated in Lumicain to remain in nail groove for 48 hours; repeat if necessary.

If hemmorrhage is profuse, dress wound with gauze saturated with Lumicain and allow to remain for 24 hours or longer.
WARNINGS AND PRECAUTIONS

CAUTION: Federal Law restricts sale and use to physician or licensed practitioner.
PRINCIPAL DISPLAY PANEL

premier lumicain TM Topical Hemostatic Solution 60cc

For Rapid Control of Minor Hemorrhage

Each Gram Contains: Aluminium Chloride............250 mg.

In an aqueous base.

Enter section text here

INGREDIENTS AND APPEARANCE

LUMICAIN
aluminium chloride hexahydrate solution

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ALUMINUM CHLORIDE (UNII: 3CYT62D3GA) (ALUMINUM CATION - UNII:3XHB1D032B)	ALUMINUM CHLORIDE	250 mg in 1 g

Ingredient Name	Strength
Inactive Ingredients
WATER (UNII: 059QF0KO0R)

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:10733-412-60	67 g in 1 BOTTLE; Type 0: Not a Combination Product	09/29/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved drug other		09/29/2010

Labeler - Medical Products Laboratories, Inc. (002290302)

Registrant - Medical Products Laboratories, Inc. (002290302)

Name	Address	ID/FEI	Business Operations
Establishment
Medical Products Laboratories, Inc.		002290302	analysis(10733-412) , manufacture(10733-412) , label(10733-412) , pack(10733-412)

View All Sections